Sign in

CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company

ATOSSA THERAPEUTICS, INC.

Sign in to watch
Ticker
ATOS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
264753208
Phone
206.588.0256
Business address
1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
Former names
ATOSSA GENETICS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy Director bought 10,000 shares at $0.70 ($7,000)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Director bought 25,000 shares at $1.77 ($44,250)
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale Former EVP, CFO, & Director sold 50,000 shares at $0.65 ($32,500)
  15. 4/A Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market buy EVP & CFO bought 50,000 shares at $0.97 ($48,500)
  20. 4 Derivatives Options or other derivatives

Page 2 of 9 · 161 filings